Literature DB >> 19429735

How reliable is pain as the fifth vital sign?

Karl A Lorenz1, Cathy D Sherbourne, Lisa R Shugarman, Lisa V Rubenstein, Li Wen, Angela Cohen, Joy R Goebel, Emily Hagenmeier, Barbara Simon, Andy Lanto, Steven M Asch.   

Abstract

BACKGROUND: Although many health care organizations require routine pain screening (eg, "5th vital sign") with the 0 to 10 numeric rating scale (NRS), its accuracy has been questioned; here we evaluated its accuracy and potential causes for error.
METHODS: We randomly surveyed veterans and reviewed their charts after outpatient encounters at 2 hospitals and 6 affiliated community sites. Using correlation and receiver operating characteristic analysis, we compared the routinely measured "5th vital sign" (nurse-recorded NRS) with a research-administered NRS (research-recorded NRS) and the Brief Pain Inventory (BPI).
RESULTS: During 528 encounters, nurse-recorded NRS and research-recorded NRS correlated moderately (r = 0.627), as did nurse-recorded NRS and BPI severity scales (r = 0.613 for pain during the last 24 hours and r = 0.588 for pain during the past week). Correlation with BPI interference was lower (r = 0.409). However, the research-recorded NRS correlated substantially with the BPI severity during the past 24 hours (r = 0.870) and BPI severity during the last week (r = 0.840). Receiver operating characteristic analysis showed similar results. Of the 98% of cases where a numeric score was recorded, 51% of patients reported their pain was rated qualitatively, rather than with a 0 to 10 scale, a practice associated with pain underestimation (chi2 = 64.04, P < .001).
CONCLUSION: Though moderately accurate, the outpatient "5th vital sign" is less accurate than under ideal circumstances. Personalizing assessment is a common clinical practice but may affect the performance of research tools such as the NRS adopted for routine use.

Entities:  

Mesh:

Year:  2009        PMID: 19429735     DOI: 10.3122/jabfm.2009.03.080162

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  26 in total

1.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Authors:  Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

2.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

3.  Sex differences in the medical care of VA patients with chronic non-cancer pain.

Authors:  Melissa B Weimer; Tara A Macey; Christina Nicolaidis; Steven K Dobscha; Jonathan P Duckart; Benjamin J Morasco
Journal:  Pain Med       Date:  2013-06-26       Impact factor: 3.750

4.  Effect of Preoperative Opioid Exposure on Healthcare Utilization and Expenditures Following Elective Abdominal Surgery.

Authors:  Jennifer F Waljee; David C Cron; Rena M Steiger; Lin Zhong; Michael J Englesbe; Chad M Brummett
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

5.  Predictors of Improvements in Pain Intensity in a National Cohort of Older Veterans With Chronic Pain.

Authors:  Steven K Dobscha; Travis I Lovejoy; Benjamin J Morasco; Anne E Kovas; Dawn M Peters; Kyle Hart; J Lucas Williams; Bentson H McFarland
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

Review 6.  Indications for Opioid Antagonists.

Authors:  O J Michael Coppes; Christine N Sang
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 7.  Prescription opioid abuse, pain and addiction: clinical issues and implications.

Authors:  Walter Ling; Larissa Mooney; Maureen Hillhouse
Journal:  Drug Alcohol Rev       Date:  2011-05

8.  Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications.

Authors:  Joseph L Goulet; Cynthia Brandt; Stephen Crystal; David A Fiellin; Cynthia Gibert; Adam J Gordon; Robert D Kerns; Stephen Maisto; Amy C Justice
Journal:  Med Care       Date:  2013-03       Impact factor: 2.983

Review 9.  Assessment and treatment of pain in thalassemia.

Authors:  Ashutosh Lal
Journal:  Ann N Y Acad Sci       Date:  2016-04-28       Impact factor: 5.691

10.  Comparative Responsiveness of the PROMIS Pain Interference Short Forms, Brief Pain Inventory, PEG, and SF-36 Bodily Pain Subscale.

Authors:  Jacob Kean; Patrick O Monahan; Kurt Kroenke; Jingwei Wu; Zhangsheng Yu; Tim E Stump; Erin E Krebs
Journal:  Med Care       Date:  2016-04       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.